High-Dose Chemotherapy Plus Autologous Stem Cell Transplantation Compared With Intermediate-Dose Chemotherapy Plus Autologous...
Performance status. *Lansky 50-100% OR. *Karnofsky 50-100%. Life expectancy. *Not specified ...https://clinicaltrials.gov/ct2/show/NCT00078988?term=stem+cell&rank=38
A Phase II Multi-institutional Study Assessing Simultaneous In-field Boost Helical Tomotherapy for 1-3 Brain Metastases - Full...
Karnofsky performance status [ Time Frame: AT approximately end of year 4 (study completion) ]. *Mini mental status exam ... Karnofsky performance status greater than or equal to 70. *Patient available for subsequent follow-up appointments and testing ...https://clinicaltrials.gov/ct2/show/NCT01543542
Corticosteroids + Bevacizumab vs. Corticosteroids + Placebo (BEST) for Radionecrosis After Radiosurgery for Brain Metastases -...
Karnofsky Performance Status ≥ 60%. * Required Initial Laboratory Values ≤14 days of registration:. 6.1 Absolute Neutrophil ...https://clinicaltrials.gov/ct2/show/NCT02490878
AX Versus AC as Adjuvant Treatment for Node-Negative Breast Cancer - Full Text View - ClinicalTrials.gov
Performance status (Karnofsky index) ,= 70.. *Normal electrocardiogram (EKG) in the 12 weeks prior to randomization. If needed ... Recruitment Status : Unknown Verified August 2011 by Peking Union Medical College Hospital. Recruitment status was: Recruiting ... Status of hormone receptors in primary tumour. Results must be available before the end of adjuvant chemotherapy. ...https://clinicaltrials.gov/ct2/show/NCT01415336
Safety Study of Afatinib for Brain Cancer - Full Text View - ClinicalTrials.gov
Karnofsky Performance Status ≥ 60%.. * Adequate organ function, defined as all of the following:. *Absolute neutrophil count ( ...https://clinicaltrials.gov/ct2/show/NCT02423525?term=brain+metastases&rank=491
Effect of Chemotherapy and Radiation Prior to Surgery for Triple Negative Breast Cancer - Full Text View - ClinicalTrials.gov
Karnofsky Performance Status of ,= 70.. *Patients with known history neural deficiencies (e.g. peripheral neuropathy). ... Recruitment Status : Terminated (Study was discontinued due to lack of accrual.) First Posted : January 29, 2008 ...https://clinicaltrials.gov/ct2/show/NCT00603408?term=10202166+%5BPUBMED-IDS%5D&rank=4
Neoadjuvant Docetaxel Plus Cisplatin and 5-fluorouracil (TPF) Followed by Concomitant Chemoradiotherapy and Chemoradiotherapy...
Karnofsky performance status ≥ 70.. *No active alcohol addiction.. *Adequate bone marrow, hepatic and renal functions ...https://clinicaltrials.gov/ct2/show/NCT00357149
Tacrolimus and Thymoglobulin, as GvHD Prophylaxis in Patients Undergoing Related Donor HCT - Full Text View - ClinicalTrials.gov
Karnofsky performance status (KPS) ,= 60, Eastern Cooperative Oncology Group (ECOG) performance status =, 2 ...https://clinicaltrials.gov/ct2/show/NCT01414127?recr=Open&cond=%22Leukemia%2C+Lymphoid%22&rank=19
Open-Label Study to Assess the Effect of Omeprazole on the Pharmacokinetics of VELCADE in Patients With Either Advanced Solid...
Karnofsky Performance Status ,/=70%; 5)Women must be menopausal. 3)Men must agree to use an acceptable method of contraception ...https://clinicaltrials.gov/ct2/show/NCT00298779
TAC Versus TCX as Adjuvant Treatment for Node-Positive Her2-Negative Breast Cancer - Full Text View - ClinicalTrials.gov
Performance status (Karnofsky index) ,= 70.. *Normal electrocardiogram (EKG) in the 12 weeks prior to randomization. If needed ... Recruitment Status : Unknown Verified January 2014 by Peking Union Medical College Hospital. Recruitment status was: Recruiting ... Status of HER2 in primary tumour, known before randomization. Patients with immune histochemistry (IHC) 0 or +1 are eligible. ... Status of hormone receptors in primary tumour. Results must be available before the end of adjuvant chemotherapy. ...https://clinicaltrials.gov/ct2/show/NCT01354522
Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Hydrochloride Before Surgery in Treating Patients With...
Lansky performance status score ,= 70 for patients =, 16 years of age. *Karnofsky performance status score ,= 70 for patients ...https://clinicaltrials.gov/ct2/show/record/NCT02180867?show_locs=Y
Lenalidomide And Rituximab as Maintenance Therapy in Treating Patients With B-Cell Non-Hodgkin Lymphoma - Full Text View -...
ECOG performance status of =, 2 at study entry; Karnofsky performance status of ,= 70% at study entry ...https://clinicaltrials.gov/ct2/show/NCT01045928?cond=%22Mantle+cell+lymphoma%22&rank=15
Ion Irradiation of Sacrococcygeal Chordoma - Full Text View - ClinicalTrials.gov
Karnofsky performance status ≥ 70%. *Patients age 18 - 80 years. *Macroscopic tumour (MRI) ...https://clinicaltrials.gov/ct2/show/NCT01811394
Yttrium Y 90 Ibritumomab Tiuxetan, Rituximab, Indium In-111 Ibritumomab Tiuxetan, Fludarabine, Melphalan, and Donor Stem Cell...
Karnofsky Performance Status (KPS) , 80. *No active Central Nervous System (CNS) disease or prior history of CNS disease ...https://clinicaltrials.gov/show/NCT00577278
Single Session Spine Stereotactic Radiosurgery in Metastatic Epidural Spinal Cord Compression - Full Text View - ClinicalTrials...
Karnofsky performance status (KPS) ,/= 40. *Patients deemed to be inoperable due to patient refusal, by neurosurgical ...https://clinicaltrials.gov/ct2/show/NCT01256554
RO4929097 and Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Brain Metastases From Breast...
Karnofsky performance status (KPS) ,= 70%; Recursive Partitioning Analysis (RPA) class I or II; a small feasibility cohort of ... Recruitment Status : Terminated (Slow accrual coupled with discontinuation of study drug.) First Posted : October 8, 2010 ... Tumor HER2/neu status may be positive or negative. *Women of childbearing potential and men must use two forms of contraception ...https://clinicaltrials.gov/ct2/show/NCT01217411?recr=Open&cond=%22Breast+Neoplasms%2C+Male%22&rank=8
Vincristine, DOXIL (Doxorubicin HCl Liposome Injection) and Dexamethasone vs. Vincristine, Doxorubicin, and Dexamethasone in...
Karnofsky performance status of ,= 60%. *Adequate bone marrow, liver and renal function ... This study will determine and compare the objective response rate (the percentage of patients who attain an Objective Status of ... To determine and compare the objective response rate (the percentage of patients who attain an Objective Status of Complete ...https://clinicaltrials.gov/ct2/show/NCT00344422
Yttrium-90 Ibritumomab Tiuxetan Plus High-Dose BEAM Followed By ASCT For Relapsed B-Cell Non-Hodgkin Lymphoma - Full Text View ...
Eastern Cooperative Oncology Group (ECOG) performance status = 0 or 1; karnofsky performance status (KPS) ,= 80 ...https://clinicaltrials.gov/show/NCT00695409
A Study of Androgen Deprivation With Leuprolide, +/- Docetaxel for Clinically Asymptomatic Prostate Cancer Participants With a...
Karnofsky performance status (KPS) ,=70 percent (%). * Adequate organ function as defined by the following laboratory criteria: ...https://clinicaltrials.gov/ct2/show/NCT00514917
Metastatic breast cancer - Wikipedia
Karnofsky performance status ≥70) fare best; older patients with a Karnofsky performance status below 70 do poorly. Effective ... although symptomatic therapy alone may be chosen for those with poor performance status. Corticosteroids are crucial to the ... Symptoms of brain metastases from breast cancer are: new-onset headache changes in mental status, cognition and behavior ataxia ... Metastatic breast cancer cells frequently differ from the preceding primary breast cancer in properties such as receptor status ...https://en.wikipedia.org/wiki/Metastatic_breast_cancer
Renal cell carcinoma - Wikipedia
... factors which may present a poor prognosis include a low Karnofsky performance-status score (a standard way of measuring ... "The current status of tailor-made medicine with molecular biomarkers for patients with clear cell renal cell carcinoma". ... current status and future perspectives". Expert Review of Anticancer Therapy. 13 (6): 697-709. doi:10.1586/era.13.52. PMID ...https://en.wikipedia.org/wiki/Renal_cell_carcinoma
List of MeSH codes (E05) - Wikipedia
... karnofsky performance status MeSH E05.318.308.250.475.730 --- sickness impact profile MeSH E05.318.308.250.580 --- mass ... health status indicators MeSH E05.318.308.250.475.365 --- apache MeSH E05.318.308.250.475.547 --- severity of illness index ...https://en.wikipedia.org/wiki/List_of_MeSH_codes_(E05)
Neutron capture therapy of cancer - Wikipedia
Karnofsky performance status), it was not possible to come up with definitive conclusions about therapeutic efficacy. However, ... 2011). "The status of Tsukuba BNCT trial: BPA-based boron neutron capture therapy combined with X-ray irradiation". Applied ... Barth, R.F.; Coderre, J.A.; Vicente, M.G.H.; Blue, T.E. (2005). "Boron neutron capture therapy of cancer: Current status and ... Start-up of the first in-hospital neutron irradiator (IHNI-1) & Presentation of the BNCT development status in China (PDF). New ...https://en.wikipedia.org/wiki/Neutron_capture_therapy_of_cancer
Index of oncology articles - Wikipedia
Karnofsky Performance Status - keloid - keratan sulfate - keratinocyte growth factor - keratoacanthoma - ketoconazole - ...https://en.wikipedia.org/wiki/Index_of_oncology_articles
David A. Karnofsky - Wikipedia
... described the Karnofsky Performance Status Scale. The primary purpose of the development of the scale was to allow physicians ... David Karnofsky was the son of Lithuanian Jewish immigrants, Sam Karnofsky, a metals buyer, and Lena Karnofsky. David graduated ... David Karnofsky on findagrave.com Burchenal JH. Obituary: David A. Karnofsky. Cancer Res. 1970:30:549-550. Karnofsky DA and ... Samuel Karnofsky on findagrave.com Karnofsky Masters Thesis/dissertation, 1936 "Oncology Luminaries: Dr. David A. Karnofsky ( ...https://en.wikipedia.org/wiki/David_A._Karnofsky